Cargando…

Experimental Animal Models of Coronavirus Infections: Strengths and Limitations

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the emergence of SARS-CoV-2 in the human population in late 2019, it has spread on an unprecedented scale worldwide leading to the first coronavirus pandemic. SARS-CoV-2 infection res...

Descripción completa

Detalles Bibliográficos
Autores principales: Casel, Mark Anthony B., Rollon, Rare G., Choi, Young Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Immunologists 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099610/
https://www.ncbi.nlm.nih.gov/pubmed/33996168
http://dx.doi.org/10.4110/in.2021.21.e12
_version_ 1783688606756372480
author Casel, Mark Anthony B.
Rollon, Rare G.
Choi, Young Ki
author_facet Casel, Mark Anthony B.
Rollon, Rare G.
Choi, Young Ki
author_sort Casel, Mark Anthony B.
collection PubMed
description Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the emergence of SARS-CoV-2 in the human population in late 2019, it has spread on an unprecedented scale worldwide leading to the first coronavirus pandemic. SARS-CoV-2 infection results in a wide range of clinical manifestations from asymptomatic to fatal cases. Although intensive research has been undertaken to increase understanding of the complex biology of SARS-CoV-2 infection, the detailed mechanisms underpinning the severe pathogenesis and interactions between the virus and the host immune response are not well understood. Thus, the development of appropriate animal models that recapitulate human clinical manifestations and immune responses against SARS-CoV-2 is crucial. Although many animal models are currently available for the study of SARS-CoV-2 infection, each has distinct advantages and disadvantages, and some models show variable results between and within species. Thus, we aim to discuss the different animal models, including mice, hamsters, ferrets, and non-human primates, employed for SARS-CoV-2 infection studies and outline their individual strengths and limitations for use in studies aimed at increasing understanding of coronavirus pathogenesis. Moreover, a significant advantage of these animal models is that they can be tailored, providing unique options specific to the scientific goals of each researcher.
format Online
Article
Text
id pubmed-8099610
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Association of Immunologists
record_format MEDLINE/PubMed
spelling pubmed-80996102021-05-14 Experimental Animal Models of Coronavirus Infections: Strengths and Limitations Casel, Mark Anthony B. Rollon, Rare G. Choi, Young Ki Immune Netw Review Article Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the emergence of SARS-CoV-2 in the human population in late 2019, it has spread on an unprecedented scale worldwide leading to the first coronavirus pandemic. SARS-CoV-2 infection results in a wide range of clinical manifestations from asymptomatic to fatal cases. Although intensive research has been undertaken to increase understanding of the complex biology of SARS-CoV-2 infection, the detailed mechanisms underpinning the severe pathogenesis and interactions between the virus and the host immune response are not well understood. Thus, the development of appropriate animal models that recapitulate human clinical manifestations and immune responses against SARS-CoV-2 is crucial. Although many animal models are currently available for the study of SARS-CoV-2 infection, each has distinct advantages and disadvantages, and some models show variable results between and within species. Thus, we aim to discuss the different animal models, including mice, hamsters, ferrets, and non-human primates, employed for SARS-CoV-2 infection studies and outline their individual strengths and limitations for use in studies aimed at increasing understanding of coronavirus pathogenesis. Moreover, a significant advantage of these animal models is that they can be tailored, providing unique options specific to the scientific goals of each researcher. The Korean Association of Immunologists 2021-04-26 /pmc/articles/PMC8099610/ /pubmed/33996168 http://dx.doi.org/10.4110/in.2021.21.e12 Text en Copyright © 2021. The Korean Association of Immunologists https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Casel, Mark Anthony B.
Rollon, Rare G.
Choi, Young Ki
Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
title Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
title_full Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
title_fullStr Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
title_full_unstemmed Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
title_short Experimental Animal Models of Coronavirus Infections: Strengths and Limitations
title_sort experimental animal models of coronavirus infections: strengths and limitations
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099610/
https://www.ncbi.nlm.nih.gov/pubmed/33996168
http://dx.doi.org/10.4110/in.2021.21.e12
work_keys_str_mv AT caselmarkanthonyb experimentalanimalmodelsofcoronavirusinfectionsstrengthsandlimitations
AT rollonrareg experimentalanimalmodelsofcoronavirusinfectionsstrengthsandlimitations
AT choiyoungki experimentalanimalmodelsofcoronavirusinfectionsstrengthsandlimitations